Virologists from the University of Leuven in Belgium have discovered that an experimental antiviral drug for treating hepatitis C may be effective in arresting or slowing the development of the Zika virus.

Confirming the detection of Zika virus in human saliva, as reported last July in the Journal of Clinical Virology.